Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Neoplasms × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 18 Recurrence 7 Leukemia, Myeloid, Acute 5 Neoplasms, Plasma Cell 4 Thymoma 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Sarcoma, Alveolar Soft Part 1 Richter's Transformation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Melanoma 1 MDS 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Glioma 1

Interventions

Docetaxel 122 Prednisone 105 Abiraterone Acetate 79 Leuprolide 76 enzalutamide 74 Radiotherapy 49 Goserelin 48 bicalutamide 45 Magnetic Resonance Spectroscopy 45 Androgen Antagonists 42 apalutamide 39 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 39 Radiosurgery 30 abiraterone 29 cabazitaxel 28 Gonadotropin-Releasing Hormone 26 Specimen Handling 25 Carboplatin 25 gallium 68 PSMA-11 23 darolutamide 23 Estramustine 22 Metformin 21 luprolide acetate gel depot 20 relugolix 19 Triptorelin Pamoate 19 Radiation 18 Pluvicto 18 Brachytherapy 18 sipuleucel-T 16 prednylidene 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02146833 2023-01-26

SHIP

Karyopharm Therapeutics Inc

Phase 2 Terminated

20 enrolled 13 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡